A shout out to two of our GMaP members who have new awards and projects: Dr. Shellie Ellis from the University of Kansas, and Dr. Irene Tami-Maury from the University of Texas, Health Science Center at Houston! Please take a moment to learn more about their exciting research efforts!
Dr. Shellie Ellis — Identifying strategies to support community-based cancer care providers in delivering precision cancer therapies!
University of Kansas researchers are conducting a study to identify strategies to support community-based cancer care providers in delivering guideline-recommended targeted cancer therapy. Investigators will conduct brief, one-time interviews with oncology providers and administrators at sites across the region to better understand successes and challenges of delivering targeted therapy and identify best practices and needs of physicians, pathologists and cancer programs in providing high-quality care. Through the study, KU investigators will also help cancer programs identify how well they are delivering targeted cancer therapy using new measures developed to capture the newer guideline-recommended targeted treatments not currently captured in other reporting systems. The study will be the first to identify how state-of-the-art targeted cancer therapy can be implemented successfully in community oncology. Non-academic oncologists from large and small, urban and rural practices are invited to participate. Watch your mail for an invitation to participate or email Dr. Shellie Ellis.
Shellie Ellis, MA, PhD, is a health services researcher and implementation scientist focused on improving cancer care delivery. Her current work focuses on understanding and guiding the adoption of evidence-based cancer innovations among cancer specialty providers, particularly cancer care providers practicing in urologic, non-academic, and rural settings. She is an Assistant Professor at the University of Kansas where she is currently principal investigator of LEARN|INFORM|RECRUIT, a multi-modal intervention facilitating community urologists’ adherence to treatment guidelines and Precision Community, an NIGMS-funded project to understand determinants of community oncologists’ use of precision medicine in cancer treatment. She is the 2019-20 Visiting Scholar to the NCI’s Cancer Care Delivery Branch collaborating with NCI staff to identify and understand rural oncology practices’ participation in cancer care delivery research.
Dr. Ellis has graduate training in medical anthropology and health services research and was awarded an NCI-funded Mentored Training in Dissemination and Implementation Research in Cancer (MT-DIRC) fellowship in 2016. She serves on national study sections as an implementation scientist and the editorial board of the new international journal Implementation Science Communications.
Dr. Ellis has almost 20 years of experience implementing evidence-based research in practice. She has implemented both screening and treatment interventions in a variety of primary and specialty settings, spanning federally qualified health centers, hospital-owned outpatient clinics and private practices in rural, urban and suburban settings. She has designed implementation strategies to promote evidence-based practice in both primary care and specialty care practices and conducted multiple studies to assess determinants of healthcare provider adoption and implementation of evidence-based practice.
firstname.lastname@example.org | www.learn-inform-recruit.org | email@example.com | https://healthcaredelivery.cancer.gov/about/visiting_scholars.html | @shellieellis7
Dr. Irene Tami-Maury — Creating tailored text-messaging to promote smoking cessation for Sexual and Gender Minorities!
Smoking among sexual and gender minority (SGM) groups, which include lesbian, gay, bisexual, and transgender (LGBT) individuals, have been reported from different sources as highly prevalent (46% for gay men and 48% for lesbians). Considering that the smoking rate within SGM groups is more than double that of the general population (19%) and that smoking accounts for at least 30% of all cancer deaths, it is clear that there is an increased risk for SGM individuals to suffer from this fatal condition. It has been suggested that targeted and tailored interventions could be more effective among SGM smokers because they assure a safe, validating environment that enhances receptivity to cessation. Although the number of people enrolled in text messaging programs for smoking cessation is increasing, no study has been conducted for evaluating its feasibility among SGM smokers. The overall goal of Dr. Tami-Maury’s study is to develop and evaluate a tailored text-messaging smoking cessation platform specifically designed to meet the needs of SGM smokers.
Irene Tami-Maury, DMD, MSc, DrPH is an Assistant Professor (Tenure-Track) in the Department of Epidemiology, Human Genetics, and Environmental Sciences at The University of Texas Health Science Center at Houston School of Public Health. She also holds an adjunct appointment at The University of Texas School of Dentistry at Houston, TX. Dr. Tami-Maury has a particular interest on two specific areas: 1) Cancer prevention and control in vulnerable populations (e.g., sexual and gender minority groups, people living with HIV/AIDS, ethnic minorities, adolescents and young adults, etc.) and 2) eHealth/mHealth research to reduce health disparities and e-learning/training for health care providers and lay health workers.